Acute and chronic renal effects of recombinant human TGF-β2 in the rat

Journal of the American Society of Nephrology

Volumn 10, Issue 6, 1999, Pages 1264-1273

  Kelly, Francis J ^a   Anderson, Sharon ^a   Thompson, Michele M ^a   Oyama, Terry T ^a   Kennefick, Thomas M ^a   Corless, Christopher L ^b   Roman, Richard J ^c   Kurtzberg, Leslie ^d   Pratt, Bruce M ^d   Ledbetter, Steven R ^d  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b PORTLAND VA MEDICAL CENTER   (United States)

^c MEDICAL COLLEGE OF WISCONSIN   (United States)

^d GENZYME CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; FUROSEMIDE; MICROSOMAL AMINOPEPTIDASE; N ACETYL BETA GLUCOSAMINIDASE; RECOMBINANT TRANSFORMING GROWTH FACTOR BETA; RENIN; THIOBUTABARBITAL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG SCREENING; GLOMERULUS FILTRATION RATE; HISTOPATHOLOGY; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY BLOOD FLOW; KIDNEY FIBROSIS; KIDNEY MEDULLA; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; SYSTOLIC BLOOD PRESSURE; URINE VOLUME;

EID: 0032997081     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Roberts AB, Sporn MB: Transforming growth factor-β. In: The Molecular and Cellular Biology of Wound Repair, edited by Clark RAF, New York, Plenum Press, 1996, pp 275-308
2. Roberts AB, Sporn MB, Lefer AM: Cardioprotective action of transforming growth factor-β. Trends Cardiovasc Med 3: 77-81, 1993
3. Pratt BM, McPherson JM: TGF-β in the central nervous system: Potential roles in ischemic injury and neurodegenerative diseases. Cytokine Growth Factor Rev 8: 267-292, 1997
4. Letterio JJ, Roberts AB: TGF-β: A critical modulator of immune cell function. Clin Immunol Immunopathol 84: 244-250, 1997
5. Border WA, Noble NA: Targeting TGF-β for treatment of disease. Nat Med 1: 1000-1001, 1995
6. Grande JP: Role of transforming growth factor-β in tissue injury and repair. Proc Soc Exp Biol Med 214: 27-40, 1997
7. Border WA, Ruoslahti E: Transforming growth factor-β in disease: The dark side of tissue repair. J Clin Invest 90: 1-7, 1992
8. Border WA, Ruoslahti E: Transforming growth factor-β in tissue fibrosis. N Engl J Med 331: 1286-1292, 1994
9. Calabresi PA, Fields NS, Maloni HW, Hanham A, Carlino J, Moore J, Levin MC, Dhib-Jalbut S, Tranquill L, Austin H, McFarland HF, Racke MK: Phase I clinical trial of transforming growth factor β2 in chronic progressive multiple sclerosis patients. Neurology 51: 289-292, 1998
10. Terrell TG, Working PK, Chow CP, Green JD: Pathology of recombinant human transforming growth factor-β1 in rats and rabbits. Int Rev Exp Pathol 34B: 43-67, 1993
11. Yamamoto TN, Noble A, Miller E, Border WA: Sustained expression of TGF-β1 underlies development of progressive kidney fibrosis. Kidney Int 45: 916-927, 1994
12. Border WA, Okuda S, Languino LR, Sporn MB, Ruoslahti E: Suppression of experimental glomerulonephritis by antiserum against transforming growth factor β1. Nature 346: 371-374, 1990
13. Kopp J, Factor V, Mozes M, Nagy P, Sanderson N, Bottinger E, Klotman P, Thorgeirsson S: Transgenic mice with increased plasma levels of TGF-β1 develop progressive renal disease. Lab Invest 74: 991-1003, 1991
14. Nakumura T, Fukui M, Ebihara I, Osada S, Nagaoka I, Tomino Y, Koide H: mRNA expression of growth factors in glomeruli from diabetic rats. Diabetes 42: 450-456, 1993
15. Yamamoto T, Nakamura T, Noble NA, Ruoslahti E, Border WA: Expression of transforming growth factor β is elevated in human and experimental diabetic nephropathy. Proc Natl Acad Sci USA 90: 1814-1818, 1993
16. Bollineni JS, Reddi AS: Transforming growth factor β1 enhances glomerular collagen synthesis in diabetic rats. Diabetes 42: 1673-1677, 1993
17. Eddy AA: Molecular insights into renal interstitial fibrosis. J Am Soc Nephrol 7: 2495-2508, 1996
18. Antonipillai I, Le TH, Soceneantu L, Horton R: Transforming growth factor-β is a renin secretagogue at picomolar concentrations. Am J Physiol 265: F537-F541, 1993
19. Schnermann JB, Zhu XL, Yang T, Huang YG, Kretzler M, Briggs JP: Regulation of endothelin production and secretion in cultured collecting duct cells by endogenous transforming growth factor-β. Endocrinology 137: 5000-5008, 1996
20. Ketteler M, Noble NA, Border WA: Transforming growth factor-β and angiotensin II: The missing link from glomerular hyperfiltration to glomerulosclerosis. Annu Rev Physiol 57: 279-295, 1995
21. Kagami S, Border WA, Noble NA: Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-β. J Clin Invest 93: 2431-2437, 1994
22. Hocher B, Thone-Reineke C, Rohmeiss P, Schmager F, Slowinski T, Burst V, Siegmund F, Quertermous T, Bauer C, Neumayer H, Schleuning W, Theuring F: Endothelin-1 transgenic mice develop glomerulosclerosis, interstitial fibrosis, and renal cysts but not hypertension. J Clin Invest 99: 1380-1389, 1997
23. Vodovotz Y, Geiser AG, Chesler L, Letterio JJ, Campbell A, Lucia S, Sporn MB, Roberts AB: Spontaneously increased production of nitric oxide and aberrant expression of the inducible nitric oxide synthase in vivo in the transforming growth factor β 1 null mouse. J Exp Med 183: 2337-2342, 1996
24. Mattson DL, Lu SH, Roman RJ, Cowley JAW: Relationship between renal perfusion pressure and blood flow in different regions of the kidney. Am J Physiol 264: R578-R583, 1993
25. Fox J, Guan S, Hymel AA, Navar LG: Dietary Na and ACE inhibition effects on renal tissue angiotensin I and II and ACE activity in rats. Am J Physiol 262: F902-F909, 1992
26. Jung K, Scholtz D: An optimized assay of alanine aminopeptidase, activity in urine. Clin Chem 26: 1251-1254, 1980
27. Wong M, Jeng AY: Determination of tissue endothelin levels. Biochem Mol Biol Int 35: 1359-1364, 1995
28. Glaser BM, Michels RG, Kuppermann BD, Sjaarda RN, Pena RA: Transforming growth factor-β2 for the treatment of full thickness macular holes: A prospective study. Ophthalmology 99: 1162-1172, 1992
29. Horikoshi S, McCune BK, Ray PE, Kopp JB, Sporn MB, Klotman PE: Water deprivation stimulates transforming growth factor β2 accumulation in the juxtaglomerular apparatus of mouse kidney. J Clin Invest 88: 2117-2122, 1991
30. Ray PE, McCune BK, Gomez AR, Ruley EJ, Klotman PE: Expression of transforming growth factor β3 in hypertrophic juxtaglomerular apparatus. N Engl J Med 330: 68-69, 1994
31. Sharma K, Ziyadeh F: Renal hypertrophy is associated with upregulation of TGF-β1 gene expression in diabetic BB rat and NOD mouse. Am J Physiol 267: F1094-F1101, 1994
32. Shihab FS, Andoh TF, Tanner AM, Bennett WM: Sodium depletion enhances fibrosis and the expression of TFG-β1 and matrix proteins in experimental chronic cyclosporine nephropathy. Am J Kidney Dis 30: 71-81, 1997
33. Khanna A, Kapur S, Sharma V, Li B, Suthanthiran M: In vivo hyperexpression of transforming growth factor β1 in mice: Stimulation by cyclosporine. Transplantation 63: 1037-1039, 1997
34. Karlsen FM, Holstein-Rathlou NH, Leyssac PP: A re-evaluation of the determinants of glomerular filtration rate. Acta Physiol Scand 155: 335-350, 1995
35. Anderson S: The relevance of single nephron studies to human glomerular function. Kidney Int 45: 384-389, 1994
36. Blantz RC, Konnen KS, Tucker BJ: Angiotensin II effects upon the glomerular microcirculation and ultrafiltration coefficient of the rat. J Clin Invest 57: 419-434, 1976
37. King AJ, Brenner BM, Anderson S: Endothelin: A potent renal and systemic vasoconstrictor peptide. Am J Physiol 256: F1051-F1058, 1989
38. Rosen S, Greenfeld Z, Brezis M: Chronic cyclosporine-induced nephropathy in the rat. Transplantation 49: 445-452, 1990
39. Elzinga LW, Rosen S, Bennett WM: Dissociation of glomerular filtration rate from tubulointerstitial fibrosis in experimental chronic cyclosporine nephropathy: Role of sodium intake. J Am Soc Nephrol 4: 214-221, 1993
40. Brezis M, Rosen S: Hypoxia of the renal medulla: Its implications for disease. N Engl J Med 332: 647-655, 1995
41. English J, Evan A, Houghton DC, Bennett WM: Cyclosporine-induced renal dysfunction in the rat. Transplantation 44: 135-141, 1987
42. Mason J: The pathophysiology of Sandimmune (cyclosporine) in man and animals. Pediatr Nephrol 4: 554-574, 1990
43. Perico N, Dadan J, Remuzzi G: Endothelin mediates the renal vasoconstriction induced by cyclosporine in the rat. J Am Soc Nephrol 1: 76-83, 1990